Stifel, Atara
Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...
GlobalData on MSN23h
Morgan Stanley, Stifel/KBW lead 2024 M&A financial adviser rankings in financial services sectorMorgan Stanley topped by deal value with $96bn in deals while Stifel/KBW led by deal volume with 37 transactions.
Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...
Wall Street analysts are buzzing with optimism as we step into 2025. There are plenty of reasons for a positive view to ...
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...
Brian Gardner, Stifel chief Washington policy strategist, joins 'Closing Bell Overtime' to talk how to play the Trump trade ...
Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Stifel Nicolaus analyst Cole McGill maintained a Buy rating on ioneer Limited (GSCCF – Research Report) today and set a price target of A$0.40.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback